FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385330596> ?p ?o ?g. }

• W4385330596 endingPage "16415" @default.
• W4385330596 startingPage "16405" @default.
• W4385330596 abstract "Metastatic castration-resistant prostate cancer (mCRPC) remains fatal and incurable, despite a variety of treatments that can delay disease progression and prolong life. Immune checkpoint therapy is a promising treatment. However, emerging evidence suggests that exosomal programmed necrosis ligand 1 (PD-L1) directly binds to PD-1 on the surface of T cells in the drain lineage lymph nodes or neutralizes administered PD-L1 antibodies, resulting in poor response to anti-PD-L1 therapy in mCRPC.Western blotting and immunofluorescence were performed to compare PD-L1 levels in exosomes derived from different prostate cancer cells. PC3 cells were subcutaneously injected into nude mice, and then ELISA assay was used to detect human specific PD-L1 in exosomes purified from mouse serum. The function of CD8+ T cells was detected by T cell mediated tumor cell killing assay and FACS analysis. A subcutaneous xenograft model was established using mouse prostate cancer cell RM1, exosomes with or without PD-L1 were injected every 3 days, and then tumor size and weight were analyzed to evaluate the effect of exosomal PD-L1.Herein, we found that exosomal-PD-L1 was taken up by tumor cells expressing low levels of PD-L1, thereby protecting them from T-cell killing. Higher levels of PD-L1 were detected in exosomes derived from the highly malignant prostate cancer PC3 and DU145 cell lines. Moreover, exosomal PD-L1 was taken up by the PD-L1-low-expressing LNCaP cell line and inhibited the killing function of CD8-T cells on tumor cells. The growth rate of RM1-derived subcutaneous tumors was decreased after knockdown of PD-L1 in tumor cells, whereas the growth rate recovered following exosomal PD-L1 tail vein injection. Furthermore, in the serum of mice with PCa subcutaneous tumors, PD-L1 was mainly present on exosomes.In summary, tumor cells share PD-L1 synergistically against T cells through exosomes. Inhibition of exosome secretion or prevention of PD-L1 sorting into exosomes may improve the therapeutic response of prostate tumors to anti-PD-L1 therapy." @default.
• W4385330596 created "2023-07-29" @default.
• W4385330596 creator A5007147493 @default.
• W4385330596 creator A5010323694 @default.
• W4385330596 creator A5029107097 @default.
• W4385330596 creator A5030921116 @default.
• W4385330596 creator A5041260237 @default.
• W4385330596 creator A5044832847 @default.
• W4385330596 creator A5058288595 @default.
• W4385330596 creator A5061140388 @default.
• W4385330596 creator A5079173563 @default.
• W4385330596 creator A5081381494 @default.
• W4385330596 date "2023-07-27" @default.
• W4385330596 modified "2023-10-15" @default.
• W4385330596 title "Prostate cancer cells synergistically defend against <scp>CD8</scp>⁺ T cells by secreting exosomal <scp>PD‐L1</scp>" @default.
• W4385330596 cites W2007445995 @default.
• W4385330596 cites W2019994586 @default.
• W4385330596 cites W2071799358 @default.
• W4385330596 cites W2143772132 @default.
• W4385330596 cites W2180120860 @default.
• W4385330596 cites W2340809809 @default.
• W4385330596 cites W2498518809 @default.
• W4385330596 cites W2578528809 @default.
• W4385330596 cites W2606966373 @default.
• W4385330596 cites W2768128044 @default.
• W4385330596 cites W2776806294 @default.
• W4385330596 cites W2783291377 @default.
• W4385330596 cites W2799997987 @default.
• W4385330596 cites W2802095881 @default.
• W4385330596 cites W2887249435 @default.
• W4385330596 cites W2891760302 @default.
• W4385330596 cites W2912991678 @default.
• W4385330596 cites W2923939395 @default.
• W4385330596 cites W2934922729 @default.
• W4385330596 cites W2943261504 @default.
• W4385330596 cites W2944131287 @default.
• W4385330596 cites W2947015633 @default.
• W4385330596 cites W2965311905 @default.
• W4385330596 cites W2967202427 @default.
• W4385330596 cites W2981768007 @default.
• W4385330596 cites W3005104290 @default.
• W4385330596 cites W3012961639 @default.
• W4385330596 cites W3040942956 @default.
• W4385330596 cites W3102777791 @default.
• W4385330596 cites W3157549915 @default.
• W4385330596 cites W3179299514 @default.
• W4385330596 cites W3197991594 @default.
• W4385330596 cites W3204403963 @default.
• W4385330596 cites W4205740972 @default.
• W4385330596 cites W4206477728 @default.
• W4385330596 cites W4206841660 @default.
• W4385330596 cites W4224103793 @default.
• W4385330596 cites W4225552231 @default.
• W4385330596 cites W4296351412 @default.
• W4385330596 cites W4304185525 @default.
• W4385330596 cites W4385330596 @default.
• W4385330596 doi "https://doi.org/10.1002/cam4.6275" @default.
• W4385330596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37501397" @default.
• W4385330596 hasPublicationYear "2023" @default.
• W4385330596 type Work @default.
• W4385330596 citedByCount "1" @default.
• W4385330596 countsByYear W43853305962023 @default.
• W4385330596 crossrefType "journal-article" @default.
• W4385330596 hasAuthorship W4385330596A5007147493 @default.
• W4385330596 hasAuthorship W4385330596A5010323694 @default.
• W4385330596 hasAuthorship W4385330596A5029107097 @default.
• W4385330596 hasAuthorship W4385330596A5030921116 @default.
• W4385330596 hasAuthorship W4385330596A5041260237 @default.
• W4385330596 hasAuthorship W4385330596A5044832847 @default.
• W4385330596 hasAuthorship W4385330596A5058288595 @default.
• W4385330596 hasAuthorship W4385330596A5061140388 @default.
• W4385330596 hasAuthorship W4385330596A5079173563 @default.
• W4385330596 hasAuthorship W4385330596A5081381494 @default.
• W4385330596 hasBestOaLocation W43853305961 @default.
• W4385330596 hasConcept C104317684 @default.
• W4385330596 hasConcept C121608353 @default.
• W4385330596 hasConcept C126322002 @default.
• W4385330596 hasConcept C145059251 @default.
• W4385330596 hasConcept C154317977 @default.
• W4385330596 hasConcept C159654299 @default.
• W4385330596 hasConcept C167672396 @default.
• W4385330596 hasConcept C185592680 @default.
• W4385330596 hasConcept C202751555 @default.
• W4385330596 hasConcept C203014093 @default.
• W4385330596 hasConcept C20518536 @default.
• W4385330596 hasConcept C2776090121 @default.
• W4385330596 hasConcept C2776438761 @default.
• W4385330596 hasConcept C2777701055 @default.
• W4385330596 hasConcept C2779723316 @default.
• W4385330596 hasConcept C2780192828 @default.
• W4385330596 hasConcept C2781053074 @default.
• W4385330596 hasConcept C2781261824 @default.
• W4385330596 hasConcept C502942594 @default.
• W4385330596 hasConcept C55493867 @default.
• W4385330596 hasConcept C71924100 @default.
• W4385330596 hasConcept C8891405 @default.
• W4385330596 hasConcept C96232424 @default.
• W4385330596 hasConceptScore W4385330596C104317684 @default.

• next